Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Barry v. Depuy Synthes Companies, No. 23-2226 (Fed. Cir. Jan. 20, 2026)

Reversed in Part
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 23-2226
Also Docketed
No. 23-2234 (consolidated; same document)
Decided
January 20, 2026
Judge
Stark, J.
Document
Precedential Opinion
Length
41 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Dr. Mark A. Barry sued DePuy Synthes Sales, Inc., Medical Device Business Services, Inc., and DePuy Syn- thes Products, Inc. (together, “DePuy”) in the United States District Court for the Eastern District of Pennsylvania, al- leging that DePuy induced surgeons to infringe certain claims of Barry’s U.S. Patent Nos. 7,670,358 (the “’358 pa- tent”), 8,361,121 (the “’121 patent”), and 9,668,787 (the “’787 patent”) (collectively, “the Asserted Paten ts”). At trial, DePuy moved to exclude two of Barry’s experts, Dr. Walid Yassir and Dr.